- Home
- OPAD vs LTRN Comparison
OPAD vs LTRN Comparison
Compare OPAD & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- LTRN
- Stock Information
- Founded
- OPAD 2015
- LTRN 2013
- Country
- OPAD United States
- LTRN United States
- Employees
- OPAD N/A
- LTRN N/A
- Industry
- OPAD Real Estate
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- LTRN Health Care
- Exchange
- OPAD Nasdaq
- LTRN Nasdaq
- Market Cap
- OPAD 43.7M
- LTRN 36.0M
- IPO Year
- OPAD N/A
- LTRN 2020
- Fundamental
- Price
- OPAD $3.81
- LTRN $4.49
- Analyst Decision
- OPAD Hold
- LTRN Strong Buy
- Analyst Count
- OPAD 5
- LTRN 1
- Target Price
- OPAD $2.41
- LTRN $25.00
- AVG Volume (30 Days)
- OPAD 8.4M
- LTRN 197.2K
- Earning Date
- OPAD 11-03-2025
- LTRN 11-06-2025
- Dividend Yield
- OPAD N/A
- LTRN N/A
- EPS Growth
- OPAD N/A
- LTRN N/A
- EPS
- OPAD N/A
- LTRN N/A
- Revenue
- OPAD $703,352,000.00
- LTRN N/A
- Revenue This Year
- OPAD N/A
- LTRN N/A
- Revenue Next Year
- OPAD $31.90
- LTRN N/A
- P/E Ratio
- OPAD N/A
- LTRN N/A
- Revenue Growth
- OPAD N/A
- LTRN N/A
- 52 Week Low
- OPAD $0.91
- LTRN $2.55
- 52 Week High
- OPAD $6.35
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- OPAD 47.35
- LTRN 55.33
- Support Level
- OPAD $3.82
- LTRN $3.89
- Resistance Level
- OPAD $4.27
- LTRN $4.55
- Average True Range (ATR)
- OPAD 0.62
- LTRN 0.33
- MACD
- OPAD -0.15
- LTRN 0.02
- Stochastic Oscillator
- OPAD 11.14
- LTRN 79.22
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.